{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:03:28Z","timestamp":1788318208654,"version":"build-2803163510"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bmc.2025.118197","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:27:28Z","timestamp":1744630048000},"page":"118197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antitumor and immunomodulatory activities of diphyllin and its derivatives"],"prefix":"10.1016","volume":"124","author":[{"given":"Yulin","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Gallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Douglas","family":"Kinghorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118197_b0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2025.118197_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-024-00998-8","article-title":"Immune evasion in cell-based immunotherapy: Unraveling challenges and novel strategies","volume":"31","author":"Li","year":"2024","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12964-023-01370-3","article-title":"Tumor immune escape: Extracellular vesicles roles and therapeutics application","volume":"22","author":"Ahmadi","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.bmc.2025.118197_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1759-7714.15178","article-title":"Advances in new targets for immunotherapy of small cell lung cancer","volume":"15","author":"Zheng","year":"2024","journal-title":"Thoracic Cancer"},{"key":"10.1016\/j.bmc.2025.118197_b0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/CM9.0000000000002991","article-title":"Recent advances and remaining challenges in lung cancer therapy","volume":"137","author":"Barr","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bmc.2025.118197_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1265865","article-title":"Progress in the clinical application of immune checkpoint inhibitors in small cell lung cancer","volume":"14","author":"He","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0035","article-title":"T cell exhaustion in human cancers","volume":"1879","author":"Kang","year":"2024","journal-title":"BBA Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118197_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","article-title":"T-cell infiltration and its regulatory mechanisms in cancers: Insights at single-cell resolution","volume":"43","author":"Yang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118197_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-024-00329-2","article-title":"Identification of cancer-specific cell surface targets for CAR-T cell therapy","volume":"44","author":"Hosen","year":"2024","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.bmc.2025.118197_b0050","article-title":"CAR-T cell therapy: Advances in digestive system malignant tumors","volume":"32","author":"Xu","year":"2024","journal-title":"Mol Ther Oncol"},{"key":"10.1016\/j.bmc.2025.118197_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00262-024-03817-z","article-title":"Breaking the shield of solid tumors: A combined approach for enhanced efficacy of CAR-T cells","volume":"74","author":"Khaliulin","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bmc.2025.118197_b0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2025.118197_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101749","article-title":"Viral- and tumor-reactive natural killer cells","volume":"67","author":"Yu","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0070","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12951-024-02746-4","article-title":"Non-viral approaches in CAR-NK cell engineering: Connecting natural killer cell biology and gene delivery","volume":"22","author":"McErlean","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.bmc.2025.118197_b0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41420-024-02077-1","article-title":"Emerging roles of CAR-NK cell therapies in tumor immunotherapy: Current status and future directions","volume":"10","author":"Zhong","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bmc.2025.118197_b0080","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1182\/bloodadvances.2022007405","article-title":"Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia","volume":"7","author":"Mansour","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.bmc.2025.118197_b0085","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1158\/0008-5472.CAN-23-1097","article-title":"Harnessing natural killer cells for lung cancer therapy","volume":"83","author":"Ma","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2025.118197_b0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41420-024-01815-9","article-title":"Breakthrough of solid tumor treatment: CAR-NK immunotherapy","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bmc.2025.118197_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1410300","article-title":"Natural products as promising modulators of breast cancer immunotherapy","volume":"15","author":"Alqathama","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155608","article-title":"Targeting CD8+ T cells with natural products for tumor therapy: Revealing insights into the mechanisms","volume":"129","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2025.118197_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155828","article-title":"Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products","volume":"132","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2025.118197_b0110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tibs.2015.08.005","article-title":"Recent insights into the structure, regulation, and function of the V-ATPases","volume":"40","author":"Cotter","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0115","doi-asserted-by":"crossref","first-page":"C392","DOI":"10.1152\/ajpcell.00442.2020","article-title":"The H+-ATPase (V-ATPase): From proton pump to signaling complex in health and disease","volume":"320","author":"Eaton","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bmc.2025.118197_b0120","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/med.21782","article-title":"Emerging insights on the role of V-ATPase in human diseases: Therapeutic challenges and opportunities","volume":"41","author":"Santos-Pereira","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2025.118197_b0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207280119","article-title":"Endocytosis triggers V-ATPase-SYK-mediated priming of cGAS activation and innate immune response","volume":"119","author":"Yang","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2025.118197_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114138","article-title":"Lysosomal dysfunction by inactivation of V-ATPase drives innate immune response in C. elegans","volume":"43","author":"Pu","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmc.2025.118197_b0135","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1901536","article-title":"Role of V-ATPase a3-subunit in mouse CTL function","volume":"204","author":"Chitirala","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0140","article-title":"Defective Lamtor5 leads to autoimmunity by deregulating V-ATPase and lysosomal acidification","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0145","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/138161212799504821","article-title":"Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer","volume":"18","author":"Hern\u00e1ndez","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2025.118197_b0150","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/cas.13240","article-title":"Cancer with low cathepsin D levels is susceptible to vacuolar (H+)-ATPase inhibition","volume":"108","author":"Kitazawa","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12964-024-01998-9","article-title":"V-ATPase in cancer: Mechanistic insights and therapeutic potentials","volume":"22","author":"Chen","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.bmc.2025.118197_b0160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/14756366.2016.1140753","article-title":"Tumor metabolism, cancer cell transporters, and microenvironmental resistance","volume":"31","author":"Alfarouk","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0165","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1002\/cam4.1594","article-title":"Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer","volume":"7","author":"Whitton","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.bmc.2025.118197_b0170","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.chembiol.2020.10.013","article-title":"Dual targeting of V-ATPase and mTORC1 signaling disarms multidrug-resistant cancers","volume":"27","author":"Turocy","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2025.118197_b0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12032-024-02313-9","article-title":"Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: New insights","volume":"41","author":"Lagzian","year":"2024","journal-title":"Med Oncol"},{"key":"10.1016\/j.bmc.2025.118197_b0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1746-1596-8-145","article-title":"The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer","volume":"8","author":"Lu","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.bmc.2025.118197_b0185","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1535-7163.MCT-13-0484","article-title":"V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells","volume":"13","author":"Schempp","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2025.118197_b0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/1535-7163.MCT-20-0662","article-title":"V-ATPase inhibition decreases mutant androgen receptor activity in castrate-resistant prostate cancer","volume":"20","author":"Whitton","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2025.118197_b0195","article-title":"KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes","volume":"18","author":"Qiao","year":"2023","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/15548627.2024.2421699","article-title":"Atractylenolide I inhibits angiogenesis and reverses sunitinib resistance in clear cell renal cell carcinoma through ATP6V0D2-mediated autophagic degradation of EPAS1\/HIF2\u03b1","volume":"21","author":"Li","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.bmc.2025.118197_b0205","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2013.06.106","article-title":"Inhibition of vacuolar H+ ATPase enhances sensitivity to tamoxifen via up-regulation of CHOP in breast cancer cells","volume":"437","author":"Jin","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2025.118197_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217075","article-title":"Novel SERCA2 inhibitor diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction","volume":"598","author":"Xu","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2025.118197_b0215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/S0102-695X2011005000196","article-title":"Chemical constituents and biological activities of species of Justicia \u2013 a review","volume":"22","author":"Corr\u00eaa","year":"2012","journal-title":"Rev Bras Farmacogn\/Braz J Pharmacogn"},{"key":"10.1016\/j.bmc.2025.118197_b0220","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/np5002785","article-title":"Potent cytotoxic arylnaphthalene lignan lactones from Phyllanthus poilanei","volume":"77","author":"Ren","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118197_b0225","first-page":"1","article-title":"Arylnaphthalene lignans with a focus Linum species: A review on phytochemical, biotechnological and pharmacological potential","volume":"71","author":"Nedelcheva","year":"2024","journal-title":"Pharmacia"},{"key":"10.1016\/j.bmc.2025.118197_b0230","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for Windows: An update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J Appl Cryst"},{"key":"10.1016\/j.bmc.2025.118197_b0235","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/S0040-4039(01)89833-6","article-title":"Revised structures of diphyllin and justicidin A","volume":"1967","author":"Govindachari","year":"1967","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2025.118197_b0240","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1021\/jo952048e","article-title":"Hindered rotation in arylnaphthalene lignans","volume":"61","author":"Charlton","year":"1996","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0245","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1021\/jo00119a041","article-title":"Efficient syntheses of 1-arylnaphthalene lignan lactones and related compounds from cyanohydrins","volume":"60","author":"Ogiku","year":"1995","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0250","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00044-012-0245-1","article-title":"Synthesis and bioevaluation of novel arylnaphthalene lignans as anticancer agents","volume":"22","author":"Zhao","year":"2013","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2025.118197_b0255","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1359\/jbmr.070613","article-title":"Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption","volume":"22","author":"S\u00f8rensen","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bmc.2025.118197_b0260","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejmech.2014.06.002","article-title":"Synthesis and identification of cytotoxic diphyllin glycosides as vacuolar H+-ATPase inhibitors","volume":"82","author":"Zhang","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0265","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/cbdd.13920","article-title":"Synthesis and evaluation of diphyllin \u03b2-hydroxyl amino derivatives as novel V-ATPase inhibitors","volume":"98","author":"Zhu","year":"2021","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2025.118197_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116537","article-title":"Evaluation of potency and metabolic stability of diphyllin-derived vacuolar-ATPase inhibitors","volume":"275","author":"Sanford","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0275","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cmdc.201800587","article-title":"Phenotypic prioritization of diphyllin derivatives that block filoviral cell entry by vacuolar (H+)-ATPase inhibition","volume":"13","author":"Lindstrom","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2025.118197_b0280","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acsinfecdis.1c00474","article-title":"Evaluation of phenol-substituted diphyllin derivatives as selective antagonists for Ebola virus entry","volume":"8","author":"Plescia","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2025.118197_b0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1573406417666201221160220","article-title":"Synthesis, cytotoxicity, anti-migration and anti-invasion activity of diphyllin heterocyclic derivatives","volume":"18","author":"Shen","year":"2022","journal-title":"Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0290","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2015.12.026","article-title":"ZT-25, a new vacuolar H+-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells","volume":"771","author":"Lu","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2025.118197_b0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41419-021-04495-w","article-title":"PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS\/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer","volume":"13","author":"Salvi","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2025.118197_b0300","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/acschembio.8b00656","article-title":"Previously uncharacterized vacuolar-type ATPase binding site discovered from structurally similar compounds with distinct mechanisms of action","volume":"14","author":"Wang","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2025.118197_b0305","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14635","article-title":"Synthesis and preliminary anticancer evaluation of 4-C derivatives of diphyllin","volume":"104","author":"Zhao","year":"2024","journal-title":"Chem Biol Drug Design"},{"key":"10.1016\/j.bmc.2025.118197_b0310","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/cbdd.14095","article-title":"2,4,5-Trideoxyhexopyranosides derivatives of diphyllin: Synthesis and anticancer activity","volume":"100","author":"Cai","year":"2022","journal-title":"Chem Biol Drug Design"},{"key":"10.1016\/j.bmc.2025.118197_b0315","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejphar.2011.05.042","article-title":"Effects of diphyllin as a novel V-ATPase inhibitor on gastric adenocarcinoma","volume":"667","author":"Shen","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2025.118197_b0320","first-page":"921","article-title":"Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells","volume":"39","author":"Chen","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmc.2025.118197_b0325","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/np50044a030","article-title":"Antitumor agents. 81. Justicidin A and diphyllin, two cytotoxic principles from Justicia procumbens","volume":"49","author":"Fukamiya","year":"1986","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118197_b0330","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5530\/jyp.2022.14.37","article-title":"Anti-proliferative and anti-migratory activities of diphyllin on human colorectal cancer cells","volume":"14","author":"Puli","year":"2022","journal-title":"J Young Pharm"},{"key":"10.1016\/j.bmc.2025.118197_b0335","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/np9900167","article-title":"Cytotoxic lignans of Justicia ciliata","volume":"62","author":"Day","year":"1999","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118197_b0340","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/np0101651","article-title":"Potent cytotoxic lignans from Justicia procumbens and their effects on nitric oxide and tumor necrosis factor-\u03b1 production in mouse macrophages","volume":"65","author":"Day","year":"2002","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118197_b0345","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.fitote.2014.01.025","article-title":"Cytotoxic activity of lignans from Justicia procumbens","volume":"94","author":"Jin","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmc.2025.118197_b0350","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/np050028u","article-title":"Cytotoxic arylnaphthalene lignans from a Vietnamese Acanthaceae, Justicia patentiflora","volume":"68","author":"Susplugas","year":"2005","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118197_b0355","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/10286020.2024.2338265","article-title":"Alkylide derivatives of diphyllin: Synthesis and preliminary anticancer evaluation","volume":"26","author":"Dong","year":"2024","journal-title":"J Asian Nat Prod Res"},{"key":"10.1016\/j.bmc.2025.118197_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114708","article-title":"Synthesis and anti-tumor activity of nitrogen-containing derivatives of the natural product diphyllin","volume":"243","author":"Li","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0365","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1002\/ejoc.201700556","article-title":"First total synthesis of the bioactive arylnaphthyl lignan 4-O-glycosides phyllanthusmin D and 4\u201c-O-acetylmananthoside B","volume":"2017","author":"Liu","year":"2017","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0370","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.phytochem.2014.12.014","article-title":"Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis","volume":"111","author":"Ren","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmc.2025.118197_b0375","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.bmc.2018.03.033","article-title":"Synthesis and antiproliferative activity of derivatives of the phyllanthusmin class of arylnaphthalene lignan lactones","volume":"26","author":"Woodard","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0380","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1158\/1535-7163.MCT-17-1195","article-title":"Phyllanthusmin derivatives induce apoptosis and reduce tumor burden in high-grade serous ovarian cancer by late-stage autophagy inhibition","volume":"17","author":"Young","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2025.118197_b0385","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2011.11.011","article-title":"Design, synthesis and biological evaluation of novel glycosylated diphyllin derivatives as topoisomerase II inhibitors","volume":"47","author":"Shi","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0390","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ardp.201200035","article-title":"Synthesis and bioevaluation of diphyllin glycosides as novel anticancer agents","volume":"345","author":"Zhao","year":"2012","journal-title":"Arch Pharm Chem Life Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0395","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/acs.jnatprod.9b00018","article-title":"Potential anticancer agents characterized from selected tropical plants","volume":"82","author":"Ren","year":"2019","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118197_b0400","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1039\/D2NP00091A","article-title":"Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer","volume":"40","author":"Mize","year":"2023","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmc.2025.118197_b0405","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s43440-019-00012-1","article-title":"Cleistanthin A inhibits the invasion of MDA-MB-231 human breast cancer cells: Involvement of the \u03b2-catenin pathway","volume":"72","author":"Liu","year":"2020","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bmc.2025.118197_b0410","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10637-010-9425-3","article-title":"D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase II\u03b1","volume":"29","author":"Gui","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bmc.2025.118197_b0415","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2174\/0929867043364531","article-title":"Etoposide: Discovery and medicinal chemistry","volume":"11","author":"Meresse","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0420","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/1061186X.2024.2315474","article-title":"Plant-based natural products in cancer therapeutics","volume":"32","author":"Mahato","year":"2024","journal-title":"J Drug Target"},{"key":"10.1016\/j.bmc.2025.118197_b0425","first-page":"747","article-title":"Structure of 4'-demethylepipodophyllotoxin","volume":"C48","author":"Sicheri","year":"1992","journal-title":"Acta Cryst"},{"key":"10.1016\/j.bmc.2025.118197_b0430","first-page":"x29","article-title":"Structure of etoposide","volume":"23","author":"Tanaka","year":"2007","journal-title":"Anal Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0435","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1055\/s-2007-993754","article-title":"Reversal of P-glycoprotein-mediated drug efflux by eudesmin from Haplophyllum perforatum and cytotoxicity pattern versus diphyllin, podophyllotoxin and etoposide","volume":"73","author":"Lim","year":"2007","journal-title":"Planta Med"},{"key":"10.1016\/j.bmc.2025.118197_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114145","article-title":"Podophyllotoxin and its derivatives: Potential anticancer agents of natural origin in cancer chemotherapy","volume":"158","author":"Motyka","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2025.118197_b0445","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0021-9258(17)40631-4","article-title":"Podophyllotoxin as a probe for the colchicine binding site of tubulin","volume":"252","author":"Cortese","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0450","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1016\/S0021-9258(18)81868-3","article-title":"The effect of podophyllotoxin on microtubule dynamics","volume":"264","author":"Schilstra","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0455","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/jcs.102.3.401","article-title":"Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis","volume":"102","author":"Jordan","year":"1992","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0460","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41589-022-01236-8","article-title":"Topoisomerase II and etoposide - a tangled tale","volume":"19","author":"Le","year":"2023","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2025.118197_b0465","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/ijerph9072444","article-title":"Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor","volume":"9","author":"Ezoe","year":"2012","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.bmc.2025.118197_b0470","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/acs.jmedchem.3c02399","article-title":"Discovery of novel isoquinoline analogues as dual tubulin polymerization\/V-ATPase inhibitors with immunogenic cell death induction","volume":"67","author":"Leng","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0475","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118197_b0480","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmc.2025.118197_b0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1359-6101(01)00022-3","article-title":"Interferon-alpha in tumor immunity and immunotherapy","volume":"13","author":"Belardelli","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bmc.2025.118197_b0490","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-21-3226","article-title":"IFN\u03b3 signaling in natural and therapy-induced antitumor responses","volume":"28","author":"Martinez-Sabadell","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118197_b0495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.bmc.2025.118197_b0500","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4236\/jibtva.2012.13004","article-title":"The natural killer cell: A historical perspective and the use of supplements to enhance NKC activity","volume":"1","author":"Thornthwaite","year":"2012","journal-title":"J Immune Based Ther Vaccines Antimicrob"},{"key":"10.1016\/j.bmc.2025.118197_b0505","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.1302600","article-title":"The natural product phyllanthusmin C enhances IFN-\u03b3 production by human NK cells through upregulation of TLR-mediated NF-\u03baB signaling","volume":"193","author":"Deng","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0510","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3389\/fimmu.2018.01509","article-title":"A synthetic disaccharide derivative of diphyllin, TAARD, activates human natural killer cells to secrete interferon-gamma via Toll-like receptor-mediated NF-\u03baB and STAT3 signaling pathways","volume":"9","author":"Yi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0515","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.dci.2003.09.008","article-title":"Tumor necrosis factors","volume":"28","author":"Goetz","year":"2004","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0520","first-page":"4.1","article-title":"TNF\/TNFR superfamily members in costimulation of Tcell responses-revisited","volume":"43","author":"Watts","year":"2025","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bmc.2025.118197_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2024.184394","article-title":"TNF receptors: Structure-function relationships and therapeutic targeting strategies","volume":"1867","author":"Lo","year":"2025","journal-title":"BBA Biomembranes"},{"key":"10.1016\/j.bmc.2025.118197_b0530","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic messengers: Tumor necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.bmc.2025.118197_b0535","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/mol.65.5.1063","article-title":"Justicidin A inhibits the transport of tumor necrosis factor-\u03b1 to cell surface in lipopolysaccharide-stimulated RAW 264.7 macrophages","volume":"65","author":"Tsao","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2025.118197_b0540","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1158\/2326-6066.CIR-22-0483","article-title":"Discovery of podofilox as a potent cGAMP-STING signaling enhancer with antitumor activity","volume":"11","author":"Han","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.bmc.2025.118197_b0545","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1021\/acsnano.1c09391","article-title":"Self-assembly of podophyllotoxin-loaded lipid bilayer nanoparticles for highly effective chemotherapy and immunotherapy via downregulation of programmed cell death ligand 1 production","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.bmc.2025.118197_b0550","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202203144","article-title":"Conjugating 4\u03b2-NH-(5-aminoindazole)-podophyllotoxin and galectin-1-targeted aptamer for synergistic chemo-immunotherapy of hepatocellular carcinoma","volume":"12","author":"Cong","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.bmc.2025.118197_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156234","article-title":"Etoposide: A rider on the cytokine storm","volume":"168","author":"Bailly","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.bmc.2025.118197_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.113379","article-title":"cGAS-STING activation by nanodelivery of teniposide achieves colorectal cancer chemo-immunotherapy","volume":"219","author":"Liao","year":"2024","journal-title":"Eur Polym J"},{"key":"10.1016\/j.bmc.2025.118197_b0565","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bmc.2025.118197_b0570","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2174\/1389557522666220117122718","article-title":"Antiviral, anticancer and hypotensive potential of diphyllin glycosides and their mechanisms of action","volume":"22","author":"Nekrakalaya","year":"2022","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.bmc.2025.118197_b0575","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.3390\/molecules28237874","article-title":"Bioactivities and mechanisms of action of diphyllin and its derivatives: A comprehensive systematic review","volume":"28","author":"Hou","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118197_b0580","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.antiviral.2013.06.014","article-title":"Inhibitory and combinatorial effect of diphyllin, a V-ATPase blocker, on influenza viruses","volume":"99","author":"Chen","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2025.118197_b0585","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ebiom.2019.08.060","article-title":"Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus","volume":"47","author":"Martinez-Lopez","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bmc.2025.118197_b0590","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/v14020354","article-title":"Diphyllin shows a broad-spectrum antiviral activity against multiple medically important enveloped RNA and DNA viruses","volume":"14","author":"\u0160tef\u00e1nik","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2025.118197_b0595","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/microorganisms9030471","article-title":"Antiviral activity of vacuolar ATPase blocker diphyllin against SARS-CoV-2","volume":"9","author":"\u0160tef\u00e1nik","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.bmc.2025.118197_b0600","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acs.jnatprod.2c00580","article-title":"Arylnaphthalene lignans with anti-SARS-CoV-2 and antiproliferative activities from the underground organs of Linum austriacum and Linum perenne","volume":"86","author":"T\u00f3th","year":"2023","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2025.118197_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199485","article-title":"Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin","volume":"350","author":"Mao","year":"2024","journal-title":"Virus Res"},{"key":"10.1016\/j.bmc.2025.118197_b0610","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12426","article-title":"Proton pump inhibitors enhance macropinocytosis-mediated extracellular vesicle endocytosis by inducing membrane V-ATPase assembly","volume":"13","author":"Lu","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.bmc.2025.118197_b0615","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202105112","article-title":"V-ATPase is a universal regulator of LC3-associated phagocytosis and non-canonical autophagy","volume":"221","author":"Hooper","year":"2022","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bmc.2025.118197_b0620","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1080\/15384101.2022.2049157","article-title":"Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations","volume":"21","author":"Qi","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bmc.2025.118197_b0625","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40164-024-00535-1","article-title":"Fueling CARs: Metabolic strategies to enhance CAR T-cell therapy","volume":"13","author":"Van der Vreken","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.bmc.2025.118197_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122856","article-title":"Recent progress in cancer vaccines and nanovaccines","volume":"314","author":"Poudel","year":"2025","journal-title":"Biomaterials"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625001385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:22:02Z","timestamp":1745482922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625001385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":126,"alternative-id":["S0968089625001385"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118197","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor and immunomodulatory activities of diphyllin and its derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118197"}}